Seminar to follow on July 9

Valneva SE will organize a virtual scientific symposium entitled “Development of new vaccines to prevent infectious diseases at home and abroad”, on July 9, 2021 at 2:15 pm CET during the 31st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).

The symposium will be chaired by Professor Thea Colsen Fischer, a Danish epidemiologist and member of the WHO team investigating the origins of SARS-CoV-2, and Catherine Dubichar, Vice President in charge of the Chikungunya Vaccine Program in Valneva.

Adam Finn, Principal Investigator in the COVID-19 Program at Valneva, Professor of Pediatrics at the University of Bristol and Chancellor at the Royal Children’s Hospital Bristol, will present phase 1/2 data from VLA2001, the only inactivated vaccine candidate against COVID-19 currently in clinical development in Europe. .

Professor Thomas Jelinek, renowned thought leader and medical director of the Berlin Center for Travel and Tropical Medicine, will also give a presentation on chikungunya and the results of a phase I study of the injectable vaccine candidate. Unique Against Chikungunya, VLA1553, from Valneva.

See also  Postponing the vaccination obligation for caregivers until December 31


Please enter your comment!
Please enter your name here